Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 26,172 shares at $8.01 ($210K) on 2023-07-10, disclosed to the SEC on 2023-07-11.
Open-market sale of $210k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.01 | 10,508 | $84K | 40.1% |
| 2 | $8.01 | 10,508 | $84K | 40.1% |
| 3 | $8.01 | 5,156 | $41K | 19.7% |
| Total | $8.01 avg | 26,172 | $210K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |